farnesyl pyrophosphate synthase bisphosphonate inhibitors (Procter & Gamble)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namefarnesyl pyrophosphate synthase bisphosphonate inhibitors (Procter & Gamble)
Drug Alias NamePG-1014491PG-1014493
ClassificationSmall molecules
Mechanisms of ActionGeranylgeranyl pyrophosphate synthase inhibitorsBone modulators
TargetsGeranylgeranyl pyrophosphate synthase
Therapy Area/IndicationsBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProcter & Gamble Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan Pharmaceuticals Ireland LtdProcter & Gamble Company
Active IndicationsN/A
Inactive IndicationsBone Diseases

Other Information

ATC CodeN/A
Related LinksN/A